Advances in Knee Osteoarthritis and Photobiomodulation Therapy

Dear Colleagues,

In the recent osteoarthritis treatment guidelines established by the National Institute of Health Care Excellence (NICE) in the U.K., therapeutic exercise and weight management are recommended alongside drug medication to alleviate pain, including topical or oral non-steroidal anti-inflammatory drugs (NSAIDs) (or paracetamol if NSAIDs are contraindicated). NSAIDs and paracetamol are known to have harmful side-effects. Those devising these guidelines were unable to recommend electrophysical agents, including acupuncture, transcutaneous electrical nerve stimulation, or photobiomodulation therapy (PBMT), due to insufficient high-quality clinical trials to evaluate their benefit or harm.

PBMT applies red and near-infrared light over sites of pathology to facilitate tissue healing, reduce inflammation, and relieve pain. PBMT includes low-level laser therapy (LLLT), high-intensity laser therapy (HILT), and light-emitting diode therapy (LEDT). It is unclear what the optimal PBMT parameters are. Both LLLT and LEDT have been studied for decades, whereas HILT has only recently become available due to advancements in equipment, and is therefore less studied. The results of a systematic review of randomized placebo-controlled trials indicates that LLLT, at ≥4 J with a wavelength of 785–860 nm and at ≥1 J with a wavelength of 904 nm per treatment spot, can reduce pain and disability associated with knee osteoarthritis in humans. Likewise, there is some evidence to support the use of LEDT and HILT.

The purpose of this Special Issue of Life is to disseminate research and catalyze debate on all matters related to the use of PBMT in knee osteoarthritis. We invite you to contribute articles on the mechanisms of action, efficacy, effectiveness, factors influencing response, technological advances, utility, and service delivery. We welcome cell and animal studies, clinical trials, narrative and systematic reviews, and viewpoint articles.

Dr. Martin Bjørn Stausholm
Prof. Dr. Jan Magnus Bjordal
Dr. Roberta Chow
Prof. Dr. Mark I. Johnson
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.